QT Medical is excited to announce its selection as a Finalist for the prestigious 2024 Digital Health Hub Foundation: Digital Health Awards. QT Medical is a Finalist in the Best in Class – Kids Health category, underscoring its leadership in transforming healthcare for children.

A Hugely successful event at CES 2022 !

19Labs and QT Medical announced a collaboration, to bring comprehensive, cost-effective, and intuitive eClinics worldwide. 19Labs' GALE eClinics come in different form factors such as portable kits, healthcare kiosks, telehealth carts — and have a growing portfolio of 25+ smart diagnostic devices. The inclusion of QT Medical's PCA 500 further advances GALE eClinic's extensive diagnostic suite with proprietary algorithms and other powerful features.

QT Medical was invited to D-Forum, D-Talk Section for sharing our experiences and  advantage in clinical applications!

QT Medical is very thrilled to partner with Philips, to bring medical standard 12-lead ECG to patients at home !

Cardiovascular disease is the second among the top ten causes of death in China. Time is the most important key to treating patients with acute myocardial infarction. In order to assist Taichung to improve emergency rescue energy, the Taiwan Branch of American Merchant Uxin Biomedical Co., Ltd. specially donated 15 sets of 12-lead ECG systems.

QT Medical announces FDA clearance of PCA 500, a resting 12-lead electrocardiogram (ECG or EKG), for use in pediatric patients. First cleared in 2018 for professional and personal use by adults 18 years and older, PCA 500's new FDA clearance expands its indication for use to all pediatric populations, including: newborns, infants, children and adolescents.

QT Medical, Inc. (QT Medical), a medtech company focusing on electrocardiogram (ECG or EKG) technology, announces today that it raised $12 million in Series B financing. This funding will accelerate QT Medical’s market penetration, global expansion, product pipeline development, and long-term strategic planning.